Design Pharmaceuticals
Focus: Design Pharmaceuticals is a Cambridge-based pharmaceutical company focused on small molecule drug design, currently operating as a generics and specialty pharma player with a portfolio of post-LOE products primarily in ophthalmology and dermatology.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Open Jobs
0
3 recent layoff filings (12 mo) — 38 affected
- 10/21/2026 — 4941 Allison Parkway Suite B Vacaville CA 95688, CA · 6 affected · Layoff Amendment
- 9/14/2026 — 4941 Allison Parkway, Suite B Vacaville CA 95688, CA · 7 affected · Closure
- 7/20/2026 — 4941 Allison Parkway, Suite B Vacaville CA 95688, CA · 25 affected · Layoff
Source: state DOL filings via Big Local News
About Design Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Design Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Design Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthWatch
Pipeline
Early-stage
50 total
LOE Risk
1 imminent
CLINDESSE
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$16M Part DDeclining
Post-LOE
Accounts for 38% of company revenue; generic carbonic anhydrase inhibitor facing post-exclusivity competitive pressure.
Help build intelligence for Design Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.